3308维多利亚线路检测(官网-认证)|主页欢迎您
En
中文
English
Home
About Us
Company Profile
Chairman's speech
Company Memorabilia
Leadership care
Honor
Cultural vision
Contact Us
News
Company News
Industry News
Investor Relations
Company Overview
Company Announcement
Products and services
Intermediates
APIs
Generic drugs
Big health food
R & D innovation
Scientific research results
Quality and Safety
Innovation dynamics
HR
Training and development
Incentive guarantee
Recruitment
Menu
CN
EN
Home
About Us
Company Profile
Chairman's speech
Company Memorabilia
Leadership care
Honor
Cultural vision
Contact Us
News
Company News
Industry News
Investor Relations
Company Overview
Company Announcement
Products and services
Intermediates
APIs
Generic drugs
Big health food
R & D innovation
Scientific research results
Quality and Safety
Innovation dynamics
HR
Training and development
Incentive guarantee
Recruitment
Intermediates
APIs
Generic drugs
Big health food
APIs
Intermediates
APIs
Generic drugs
Big health food
Canagliflozin Hemihydrate
category：APIs
release date：2021-10-11
SPECIFICATION: In-House
DOCUMENTATION: DMF
CAS NO. : 928672-86-0
INDICATION: Diabetes
Next：None
Back
Related Products
Solifenacin Succinate
Apremilast
Mirabegron
Tofacitinib Citrate
Empagliflozin
Canagliflozin Hemihydrate
Duloxetine HCl
Levetiracetam
Ozenoxacin
Vonoprazan Fumarate
Address：No.15 Shuangfeng Rd., Fotang, Yiwu, Zhejiang 322002, China
Copyright © 2021 Zhejiang Huayi Pharmaceutical Co., Ltd. All rights reserved.
ICPNo. 浙05012164
About Us
Company Profile
Chairman's speech
Company Memorabilia
Leadership care
Honor
Cultural vision
Contact Us
News
Company News
Industry News
Investor Relations
Company Overview
Company Announcement
Products and services
Intermediates
APIs
Generic drugs
Big health food
R & D innovation
Scientific research results
Quality and Safety
Innovation dynamics
HR
Training and development
Incentive guarantee
Recruitment
Copyright © 2021 Zhejiang Huayi Pharmaceutical Co., Ltd.
ICPNo. 浙05012164
by:e7cn.net
